Role of biomarkers in the diagnosis and management of HCC

By sjmartinez • May 14, 2024

Alhasan M, Mehta N, Yang JD, Singal AG. Role of biomarkers in the diagnosis and management of HCC. Liver Transpl. 2024 May 14. doi: 10.1097/LVT.0000000000000398. Epub ahead of print. PMID: 38738964.

Tags: Cedars Sinai DoM, Digestive Diseases, Publications

Related Posts

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions

Patil T, Lin JJ, Cheema PK, Carrizosa DR, Burkard ME, Elamin YY, Desai J, Patel JD, Nagasaka M, Reckamp KL, Waqar SN, Bauman JR, Schram[...]

Deep Learning-Based Denoising for High-Resolution Carotid Vessel Wall MRI Using Standard Neurovascular Coils

Zeng L, Hsu YC, Wang L, Lu M, Keushkerian M, Nguyen KL, Johnson KJ, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner[...]

Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement

Whitley MJ, Wang JX, Chapman J, de Vries APJ, Chandran S, Glennon CM, Madariaga HM, Carroll RP, Booth J, Concepcion B, Couzi L, De Serres[...]